Chlorambucil,Venetoclax,Obinutuzumab
roche,GSK,abbvie
['congrat', 'cll']
updated results cll14 trial 1l in less fit cll pts, ven-g vs. g-clb. despite tp53 and ighv retaining prognostic value for pfs, still very good for tp53 aberrations and u-ighv. w/ven-g congrats to , kirsten fischer, dcllsg and all investigators 
Hematologist at https://t.co/5Cv9rH6CW0; CLL expert. Professor at https://t.co/iQLiqw0Vhp. Evidence-based medicine. Trumpet / chess / golf player. Tweets are solely my personal views.